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Background: Haemophilus ducreyi is the bacterium responsible for the genital ulcer disease chancroid, a cofactor
for the transmission of HIV, and it is resistant to many antibiotics. With the goal of exploring possible alternative
treatments, we tested essential oils (EOs) for their efficacy as antimicrobial agents against H. ducreyi.
Methods: We determine the minimum inhibitory concentration (MIC) of Cinnamomum verum (cinnamon), Eugenia
caryophyllus (clove) and Thymus satureioides (thyme) oil against 9 strains of H. ducreyi using the agar dilution method.
We also determined the minimum lethal concentration for each oil by subculturing from the MIC plates onto fresh
agar without essential oil. For both tests, we used a 2-way ANOVA to evaluate whether antibiotic-resistant strains had a
different sensitivity to the oils relative to non-resistant strains.
Results: All 3 oils demonstrated excellent activity against H. ducreyi, with MICs of 0.05 to 0.52 mg/mL and MLCs of
0.1-0.5 mg/mL. Antibiotic-resistant strains of H. ducreyi were equally susceptible to these 3 essential oils relative to
non-resistant strains (p = 0.409).
Conclusion: E. caryophyllus, C. verum and T. satureioides oils are promising alternatives to antibiotic treatment for
chancroid.
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Haemophilus ducreyi, a Gram-negative coccobacillus, is a
strict human pathogen responsible for the development of
chancroid, which is a sexually transmitted infection (STI)
that causes the formation of genital ulcers 4–10 days after
acquisition of the bacteria and persists in some cases for
1–3 months. While relatively rare in the United States,
chancroid is more prevalent in regions of Africa, Asia and
Latin America due in part to the limited availability of
health-care resources such as antibiotics. As there is no
current vaccine for chancroid, treatment focuses on the
use of antibiotics, typically 500 mg of ciprofloxacin admin-
istered orally twice a day for three days, although azithro-
mycin, ceftriaxone, and erythromycin are also common [1].
Although no one strain of H. ducreyi demonstrates the
wide range of and high degree of antibiotic resistance that
is found in some bacteria, an increasing number of strains
of H. ducreyi have developed some degree of antibiotic* Correspondence: thumphre@allegheny.edu
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unless otherwise stated.resistance [2]. Beginning in the 1970’s, strains of H. ducreyi
emerged that possessed resistance to penicillin and its deriv-
atives [3]. Subsequently, strains of H. ducreyi demonstrated
resistance to sulfonamides, aminoglycosides, tetracyclines,
and chloramphenicol [4]. The development of antibiotic re-
sistance in H. ducreyi is of particular concern given the con-
nection between HIV-1 and chancroid [5]. Genital ulcer
diseases (GUDs), which include chancroid, are a known co-
factor for HIV transmission; people with a GUD are 50–300
times more likely to contract HIV per unprotected act of va-
ginal intercourse. In many areas where HIV is prevalent,
chancroid is the most common GUD [5]. Therefore, treat-
ment of chancroid seems likely to help prevent the spread
of HIV, especially in impoverished regions of the developing
world with poor health care institutions.
With the increasing resistance of strains of H. ducreyi to
antibiotics currently in use and the threat that chancroid
contributes to the spread of HIV, it seems prudent to
search for alternatives to the current methods of treatment
for chancroid. One such alternative that has shown prom-
ise in the treatment of other bacteria but has never beenral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ically diverse group of plant-derived compounds, many
of which have antibacterial properties [6]. Importantly, the
antibacterial activity of essential oils is as potent against
bacterial strains with antibiotic resistance as their non-
resistant counterparts [7]. For example, MRSA is suscep-
tible to thyme white oil, lemon oil, lemongrass oil, and
cinnamon oil [7]. The susceptibility of STIs to essential
oils is not well studied, although Neisseria gonorrhoeae is
susceptible to the essential oil of Croton gratissimus [8].
Based on the antibacterial effects of a wide variety of es-
sential oils, we determined the minimum inhibitory con-
centrations (MICs) and minimum lethal concentrations
(MLCs) of E. caryophyllus, C. verum and T. satureioides
using the agar dilution method [7,9]. Based on our results,
H. ducreyi is more susceptible to C. verum, T. satureioides
and E. caryophyllus than any of the control organisms,
making all of three oils excellent candidates for clinical tri-
als in future studies.Methods
Selection of bacterial species
Nine strains of Haemophilus ducreyi were chosen to re-
flect the varying degrees of antibiotic resistance found
clinically: 35000HP, CIP542, HMC46 (PcR, TcR, CmR),
HMC48 (PcR, TcR, CmR), HMC56 (PcR, TcR), HMC88
(PcR, TcR, CmR, TMPR, StrR, KanR), HMC49, HMC53
(PcR, TcR, CmR) and HMC112 [10]. In addition, Escheri-
chia coli K-12, Pseudomonas aeruginosa 49189 (ATCC,
Manassa, VA, USA), Lactobacillus reuteri HM-102 (BEI
Resources, Manassas, VA, USA), and Staphylococcus aur-
eus strain +4651 (Presque Isle Cultures, Erie, PA, USA)
were used as controls. All strains of H. ducreyi were pro-
vided courtesy of Stanley Spinola (Indiana University
School of Medicine) or Patricia Totten (University of
Washington). S. aureus and E. coli were chosen as positive
controls because all selected essential oils are effective
bacteriostatic agents against both [9]. P. aeruginosa was
chosen as a control representing relative resistance to es-
sential oils, being resistant to most essential oils except
cinnamon and oregano [9]. L. reuteri was chosen as a rep-
resentative of the many Lactobacillus species that make
up the vaginal flora. The susceptibility of L. reuteri is un-
known, although Lactobacillus strains are resistant to tea
tree oil concentrations up to 2.0% [11].Essential oils tested
The following pure essential oils were selected for ana-
lysis: Eugenia caryophyllus (clove), Cinnamomum verum
(cinnamon), and Thymus satureioides (thyme). All essen-
tial oils were purchased from NOW Foods (Bloomingdale,
IL, USA).Determination of minimum inhibitory concentrations (MICs)
MICs were determined by the agar-dilution method based
on the Clinical and Laboratory Standards Institute guide-
lines [6,8]. Each essential oil was diluted in sterile 0.15%
agar solution [9]. Twofold serial dilutions of each essential
oil were performed to create dilutions of each essential oil
ranging from 2.5% to 0.001% (mg/mL varies by density of
each oil). Chocolate agar plates were inoculated and incu-
bated as previously described.
L. reuteri was grown at 33°C in a 10% CO2 incubator.
All other control organisms were grown at 37°C. After
the initial screen, the range of concentrations tested in
subsequent assays was narrowed down to the three con-
centrations nearest to the apparent MIC. Each strain/
concentration combination was tested in triplicate for
each assay, and the entire assay was repeated three
times for each of the strains of H. ducreyi tested, as well
as for all control organisms. MICs were defined as the
lowest concentration of oil for which there was no vis-
ible bacterial growth on any of the plates assayed [9].
Determination of minimum lethal concentrations (MLCs)
Subcultures were taken from each of the chocolate agar
plates used in the MIC assays that exhibited no growth
after 36 hours. A sterile wire loop was used to scrape the
surface of the agar and any bacteria present were thus
transferred to a fresh chocolate agar plate that lacked any
essential oil and incubated for 24–72 hours. The lowest
concentration of an essential oil from which the bacteria
failed to grow within 24–72 hours (depending on the rela-
tive normal growth rates of each strain of bacteria tested)
after being transferred to a new chocolate agar plate was
defined as the MLC.
Data analysis
Each phase of this study was performed in triplicate. Mean
values for the MICs and MLCs were calculated for each
essential oil. A 2-way ANOVA was used to analyze the dif-
ferences in MIC and MLC between resistant and non-
resistant strains. Differences in values of p < 0.05 were
considered significant. Data were analyzed with IBM SPSS
Statistics, Version 19 (IBM Corporation, Armonk, NY).
Results and discussion
MICs were determined for C. verum, E. caryophyllus, and
T. satureioides using the agar dilution method. E. caryo-
phyllus had the most potent antibacterial effects out of the
essential oils tested, with an MIC of 0.085 ± 0.03 mg/mL
(mean ± SD) and an MLC of 0.14 ± 0.07 mg/mL (mean ±
SD). However, both C. verum and T. satureioides were rela-
tively effective as well, with MICs of 0.23 ± 0.14 mg/mL
and 0.29 ± 0.11 mg/mL (mean ± SD), respectively (Table 1).
According to Ríos and Recio’s criteria [6], E. caryophyllus is
the most promising oil as the MIC and MLC for most
Table 1 MICsa and MLCsb of essential oils against
antibiotic resistant and sensitive strains of H. ducreyi
E. caryophyllus C. verum T. satureioides
Organism MIC MLC MIC MLC MIC MLC
H. ducreyi
35000HP 0.104 0.260 0.103 0.260 0.460 0.460
HMC112 0.050 0.104 0.103 0.260 0.230 0.230
HMC46c 0.050 0.104 0.520 0.520 0.230 0.460
HMC48c 0.104 0.104 0.260 0.520 0.230 0.230
HMC56c 0.050 0.104 0.260 0.260 0.230 0.460
HMC88c 0.104 0.104 0.260 0.260 0.230 0.460
HMC49c 0.104 0.104 0.260 0.260 0.460 0.460
HMC53c 0.104 0.260 0.260 0.260 0.230 0.230
CIP542ATCC NDd NDd 0.050 0.050 NDd NDd
Controls
E. coli 2.6 2.6 25.8 25.8 4.6 4.6
S. aureus 2.6 2.6 10.3 25.8 4.6 4.6
P. aeruginosa 5.2 10.4 5.2 5.2 9.2 9.2
L. reuteri ≥2.6 ≥2.6 5.2 10.3 4.6 4.6
MIC and MLC are reported in mg/mL. For all strains shown, n = 3.
aMinimum inhibitory concentration (MIC) is the lowest concentration of
oil-infused agar on which no growth occurred.
bMinimum lethal concentration (MLC) is the concentration of oil-infused agar
from which no growth occurred after transfer to fresh agar without essential oil.
cDenotes resistance to penicillin, tetracycline, kanamycin, and chloramphenicol.
dNot done; due to the extremely fastidious growth requirements of this strain,
sufficient growth was not obtained to determine the MIC and MLC for these oils.
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control organisms had at least 10-fold higher MICs and
MLCs than any of the strains of H. ducreyi for each of the
oils tested, suggesting that these essential oils may be par-
ticularly effective against H. ducreyi (Table 1). In the MLC
assay, the antibiotic resistant strains of H. ducreyi were
equally susceptible to the essential oils as the strains with-
out antibiotic resistance (p = 0.409), as is the case with pre-
vious studies [7,9], (Table 1). There was no interaction
between the type of oil and antibiotic resistance (p = 0.227).
Based on the results of this study, the essential oils of
C. verum, T. satureioides, and E. caryophyllus all are po-
tent bactericides against H. ducreyi. Therefore, any of
these three essential oils would be a promising alternative
to antibiotics. However, although the effectiveness of all es-
sential oils tested varied based on the strain of H. ducreyi,
for each strain we tested E. caryophyllus oil had either the
lowest MLC or was tied for the lowest MLC with either
C. verum or T. satureioides (Table 1). Therefore, E. caryo-
phyllus oil in particular provides an excellent opportunity
for further study.
The viability of E. caryophyllus oil as a potential treat-
ment for chancroid is further supported by the results we
obtained for our control organisms, particularly L. reuteri.
Lactobacillus species are a large component of the flora inthe female reproductive tract and play an important role in
protecting the vaginal environment from invasion by for-
eign pathogens [12]. This is especially important in the
treatment of chancroid because disrupting the Lactobacillus
species in the vagina can increase the susceptibility to HIV
[13]. Therefore, a suitable potential treatment for chancroid
would ideally be harmless to natural flora. Although L. reu-
teri is a resident of the gut, rather than vagina, it was
chosen as a representative of the Lactobacillus species that
inhabit the vagina because it grows most readily on choc-
olate agar. Importantly, we found that L. reuteri is much
more tolerant (at least tenfold higher MLCs for each oil) of
C. verum, T. satureioides, and E. caryophyllus oils than H.
ducreyi (Table 1). It is therefore likely that MLC doses of
these three oils for H. ducreyi would have no adverse effects
on host flora.
Another quality of essential oils that would make them a
good alternative treatment for chancroid is their low cyto-
toxicity. Because chancroid is a genital ulcer disease, topical
administration appears to be the most likely choice. When
administered topically, essential oils have low toxicity pro-
vided they are diluted to at least 3%-4% in carrier oil [14].
Possible side effects of essential oils applied to the skin are
confined to irritation or allergic reactions [15]. However,
because the MLCs for C. verum, E. caryophyllus, and T.
satureioides range from 0.01-0.05% (ca. 0.1-0.5 mg/mL), it
is unlikely that such side effects would occur (Table 1).
Conclusions
Based on the results of this study, C. verum (cinnamon),
T. satureioides (thyme), and particularly E. caryophyllus
(clove) oil would all make excellent candidates for an al-
ternative treatment for chancroid that would be rela-
tively risk free and cheaply produced. We recommend
further study to assess the antibacterial activity of these
oils in vivo.
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